Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Safety, and Efficacy of IV Buprenorphine in Pediatric Patients
NCT01324544Phase 3Withdrawn
- Sponsor
- Purdue Pharma
- Start
- Nov 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of buprenorphine extended-release injection in acute pain, sponsored by Purdue Pharma. Planned start Nov 2011; status: withdrawn.
02
Drugs
buprenorphine extended-release injection
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01324544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01324544.